Frequently, countries show interest in joining Eurotransplant. For this purpose a transparent accession procedure has been developed. In seven steps candidate member states are assisted to full membership of the Eurotransplant community.
A potential member state expresses interest in Eurotransplant. The Ministry of Health and/or the professional transplant community confirm cooperation is considered as beneficial. Preferably both the ministry and the transplant community acknowledge the benefit.
A meeting between the potential member state and the President and Directors of Eurotransplant takes place. During the meeting the prerequisites for new Eurotransplant member countries are discussed and the compliance of the potential new member is screened.
If both parties are still interested, then the potential member state implements the prerequisites for joining Eurotransplant. The Eurotransplant Reference Laboratory performs a Risk Assessment of Quality of Human Leukocyte Antigens (HLA) Diagnostics.
The Board and Director of Eurotransplant assess the risks with regard to:
Depending on the outcome of the risk assessments, the Board of ET may conclude that offering a Preliminary Cooperation Agreement (PCA) is appropriate. The President and the Directors will start the negotiations with the potential member state.
As soon as the negotiations on the PCA are concluded successfully, a 'professional and scientific' exchange of views and experiences between professional communities of the potential member state and Eurotransplant is organized. Also the training of key personnel in the potential member state is organized.
The Board of Eurotransplant evaluates the preliminary cooperation with the potential member state.
If the cooperation is to the satisfaction of Eurotransplant as well as to the potential member state, the time has arrived for the final step: accession of the potential member state into the Eurotransplant community.